GYRE icon

Gyre Therapeutics
GYRE

Overview Fund Activity

76 hedge funds and large institutions have $135M invested in Gyre Therapeutics in 2013 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 5 closing their positions.

Holders
76
Holders Change
+3
Holders Change %
+4.11%
% of All Funds
2.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
29
Reduced
23
Closed
5
Calls
$1.73M
Puts
$5.08M
Net Calls
-$3.35M
Net Calls Change
+$2.12M

Top Buyers

1
BBA
1
Baker Bros. Advisors
New York
$11M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$4.03M
3
HVC
3
Healthcare Value Capital
New Jersey
$1.08M
4
JGC
4
J. Goldman & Co
New York
$929K
5
Franklin Resources
5
Franklin Resources
California
$6.24M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$2.22M
2
RFC
2
Russell Frank Company
Washington
$223K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$0
4
CCMH
4
Cornerstone Capital Management Holdings
New York
$266K
5
Morgan Stanley
5
Morgan Stanley
New York
$242K
Name Market Value Shares Shares
Change 		Shares
Change %
Susquehanna International Group
76
Susquehanna International Group
Pennsylvania
– – -117,354 Closed
DTL
77
Dynamic Technology Lab
Singapore
– – -39,154 Closed
HCM
78
Highbridge Capital Management
New York
– – -21,066 Closed
Jane Street
79
Jane Street
New York
– – -12,528 Closed
BNP Paribas Financial Markets
80
BNP Paribas Financial Markets
France
– – -11,559 Closed
U
81
UBS
Switzerland
– – – –
SM
82
Sabby Management
Florida
– – – –
Wells Fargo
83
Wells Fargo
California
$0 1 – –
1 2 3
4